- Previous Close
1.6550 - Open
1.5900 - Bid 1.5000 x --
- Ask 1.5800 x --
- Day's Range
1.4900 - 1.5900 - 52 Week Range
0.8200 - 2.0800 - Volume
2,276,569 - Avg. Volume
715,065 - Market Cap (intraday)
559.277M - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.93
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. EBR Systems, Inc. was incorporated in 2003 and is based in Sunnyvale, California.
ebrsystemsinc.comRecent News: EBR.AX
View MorePerformance Overview: EBR.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EBR.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EBR.AX
View MoreValuation Measures
Market Cap
559.28M
Enterprise Value
528.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
14.38
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-31.42%
Return on Equity (ttm)
-147.25%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-40.8M
Diluted EPS (ttm)
-0.2100
Balance Sheet and Cash Flow
Total Cash (mrq)
60.66M
Total Debt/Equity (mrq)
169.98%
Levered Free Cash Flow (ttm)
-24.82M